Opioid Use Disorder Treatment Market Growth, Analysis, Trends and Forecast 2023 to 2033

According to market predictions, the global Opioid Use Disorder Treatment market revenue will be worth US$ 3.07 billion in 2023 and will grow at a CAGR of 10.5% during the forecast period, reaching US$ 8.4 billion by 2033. The providers and manufacturers of drug abuse therapy are primarily concerned with raising public and drug store owner knowledge of the dangers of drug misuse and the importance of obtaining treatment. This technique contributes to the expansion of the Opioid Use Disorder Treatment business by increasing their customer base. Various media, such as television commercials, newspapers, and information brochures, are being used effectively to raise awareness and combat the opioid epidemic.

Collaborations between diverse organisations are also fueling the industry's growth. For example, GlaxoSmithKline collaborated with 2morrow Inc., the producer of the SmartQuit app, in March 2016 to deliver patches to smokers who adhered to the app's plan. Similarly, in August 2013, the business agreed to collaborate with Amneal Pharmaceuticals LLC to offer its generic version of Suboxon, Buprenorphine HCl and Naloxone HCl Dihydrate Sublingual Tablets (CIII), to addiction treatment centres. In the long run, these collaborations are projected to assist the opioid use disorder therapy market.

Competitive Landscape

The market for Opioid Use Disorder Treatment is competitive, with numerous significant companies. Major players are developing innovative opioid delivery methods to treat opioid use disorder. This is projected to push the market for Opioid Use Disorder Treatment. The major players in the market are: Trevena, Opiate Pharmaceutical, Aphios, Kyowa kirin, Gamida-Cell, Novartis, Titan Pharmaceuticals, Inc., Hikma Pharmaceuticals, MediciNova, Alkermes, Inc., BioDelivery Sciences International, Inc.

Browse More Details@ https://www.futuremarketinsights.com/reports/opioid-use-disorder-treatment-market

Key Segments Profiled in the Opioid Use Disorder Treatment Market Survey

By Drug Type:

  • Romiplostim
  • Omidubicel
  • Nalmefene
  • Buprenorfine
  • Methadone
  • Naltrexone

By Route of Administration:

  • Oral
  • Parenteral

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Comments

Popular posts from this blog

Handheld Ultrasound Scanners Market Will Generate Booming Growth Opportunities to 2032

Global Medical face shield Market Insights and Outlook 2022-2032

Aesthetic Medical Devices Market 2022-2032: Advanced R&D Process Strategies